Safi Biotherapeutics, Inc.
Safi Biotherapeutics is focused on developing blood cell therapies, including on-demand red blood cells for trauma and specific transfusions. They aim to overcome manufacturing challenges of cell therapy by integrating expertise in blood stem cell expansion, bioprocessing, and cryostorage, with a mission to create scalable, consistent, and economically viable blood products.
Industries
Nr. of Employees
small (1-50)
Products
Manufactured red blood cells for transfusion (on-demand)
Red blood cells produced via ex vivo manufacturing intended for acute transfusion (trauma) and tailored transfusions for specific disease indications.
Manufactured red blood cells for transfusion (on-demand)
Red blood cells produced via ex vivo manufacturing intended for acute transfusion (trauma) and tailored transfusions for specific disease indications.
Services
Partnership role to commercialize on-demand blood product manufacturing as part of government and defense programs.
Collaborative research and validation services to assess health, quality and cryopreservation of manufactured red blood cells with external partners.
Partnership role to commercialize on-demand blood product manufacturing as part of government and defense programs.
Collaborative research and validation services to assess health, quality and cryopreservation of manufactured red blood cells with external partners.
Expertise Areas
- Ex vivo cell therapy manufacturing
- Hematopoietic stem cell expansion
- Bioprocess optimization and scale-up
- Cryopreservation and cryostorage for cell products
Key Technologies
- Blood cell culture and expansion
- Hematopoietic progenitor differentiation protocols
- Bioreactor-based scale-up
- Cryopreservation technologies